Plasmodium vivax circumsporozoite genotypes: A limited variation or new subspecies with major biological consequences?

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Souza Neiras, Wanessa C ^a   Storti Melo, Luciane M ^a   Cassiano, Gustavo C ^a   Couto, Vanja S C A ^b   Couto, Álvaro A R A ^b   Soares, Irene S ^c   Carvalho, Luzia H ^d   Cunha, Maristela G ^e   Póvoa, Marinete M ^f   Herrera, Socrates ^g   Herrera, Myriam A ^g   Rossit, Andrea R B ^h   Carareto, Claudia M A ^a   Machado, Ricardo L D ^h  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Faculdade SEAMA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^f INSTITUTO EVANDRO CHAGAS   (Brazil)

^g UNIVERSIDAD DEL VALLE   (Colombia)

^h FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CIRCUMSPOROZOITE PROTEIN; DUFFY BINDING PROTEIN; IMMUNOGLOBULIN G ANTIBODY; MEROZOITE SURFACE PROTEIN 1; APICAL MEMBRANE ANTIGEN I, PLASMODIUM; CELL SURFACE RECEPTOR; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; CYTOCHROME B; DUFFY ANTIGEN BINDING PROTEIN, PLASMODIUM; MEMBRANE PROTEIN; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ANTIBODY RESPONSE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC VARIABILITY; GENOTYPE; HUMAN; PHYLOGENY; PLASMODIUM VIVAX; CLASSIFICATION; DNA SEQUENCE; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE REPEAT; PARASITOLOGY; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION;

ANTIGENS, PROTOZOAN; CYTOCHROMES B; GENETIC VARIATION; GENOTYPE; HUMANS; MALARIA, VIVAX; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PHYLOGENY; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA;

EID: 77953695991     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-178     Document Type: Article

References (51)

1. Plasmodium sporozoite molecular cell biology. SH Kappe CA Buscaglia V Nussenzweig, Annu Rev Cell Dev Biol 2004 20 29 59 10.1146/annurev.cellbio.20. 011603.150935 15473834
2. Migration through host cells: the first steps of Plasmodium sporozoites in the mammalian host. MM Mota A Rodriguez, Cell Microbiol 2004 20 29 59
3. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immonodominant epitope. DE Arnot JW Barnwell JP Tam V Nussenzweig RS Nussenzweig, Science 1985 230 815 817 10.1126/science.2414847 2414847
4. Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. R Rosenberg RA Wirtz DE Lanar J Sattabongkot T Hall AP Waters C Prasittisuk, Science 1989 245 973 976 10.1126/science.2672336 2672336
5. Identification of Plasmodium vivax-like human malaria parasite. SH Qari YP Shi IF Goldman V Udhayakumar MP Alpers WE Collins AA Lal, The Lancet 1993 341 780 783 10.1016/0140-6736(93)90559-Y (Pubitemid 23096285)
6. Global occurrence of Plasmodium vivax-like human malaria parasite. SH Qari YP Shi MP Póvoa MM Alpers P Deloron GS Murphy S Harjosuwarno AA Lal, J Infect Dis 1993 168 1485 1489 8245533
7. Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens. KC Kain AE Brown HK Webster RA Witz JS Keystone MH Rodriguez J Kinahan M Rowland DE Lanar, J Clin Microbiol 1992 30 1863 1866 1629344
8. A seroprevalence and descriptive epidemiological study of malaria among Indian tribes of the Amazon basin of Brazil. ME Arruda C Aragaki F Gagliardi RW Halle, Ann Trop Med Parasitol 1996 90 135 143 8762403
9. Prevalence of Plasmodium vivax variants VK247 and P. vivax-like human malaria: a retrospective study in Indian populations of the Amazon region of Brazil. ME Arruda RC De Souza ME Veiga AF Ferreira RH Zimmerman, Trans R Soc Trop Med Hyg 1998 92 628 10.1016/S0035-9203(98)90788-X 10326105
10. Serological investigation of human Plasmodium vivax-like malaria in several localities in the State of São Paulo, Brazil. II Curado AMRC Duarte AA Lal RS Nussenzweig S Oliveira JK Kloetzel, Mem Inst Oswaldo Cruz 1995 90 Suppl 1 284
11. Distribution of Plasmodium vivax variants (VK210, VK247 and P. vivax-like) in three endemic areas of Amazonian Brazil and their correlation with chloroquine-treatment. RLD Machado MM Póvoa, Trans R Soc Trop Med Hyg 2000 94 377 381 10.1016/S0035-9203(00)90110-X 11127238
12. Variants of the Plasmodium vivax circumsporozoite protein (VK210 and VK247) in Colombian isolates. JM Gonzalez S Hurtado M Arévalo-Herrera S Herrera, Mem Inst Oswaldo Cruz 2001 96 709 712 11500776
13. HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria. J Oliveira-Ferreira LR Pratt-Riccio M Arruda F Santos CT Ribeiro AC Goldberg DM Banic, Acta Trop 2004 92 63 69 10.1016/j.actatropica.2004.02.011 15301976
14. Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgamI as genetic marker. M Imwong S Pukrittayakamee AC Gruner L Renia F Letourneur S Looaresuwan NJ White G Snounou, Exp Parasitol 2005 99 175 179 10.1006/expr.2001.4646
15. Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran. S Zakeri A Abouie-Mehrizi ND Djadid G Snounou, Trop Med Int Health 2006 11 729 737 10.1111/j.1365-3156.2006.01613.x 16640626
16. Malaria epidemiology in low-endemicity areas of the Atlantic Forest in the Vale do Ribeira, São Paulo, Brazil. I Curado RS Malafronte AMRC Duarte K Kirchgatter MS Branquinho EAB Galati, Acta Trop 2006 100 54 62 10.1016/j.actatropica.2006.09.010 17126279
17. Plasmodium vivax circumsporozoite variants and Duffy blood group genotypes in the Brazilian Amazon region. LM Storti-Melo WC Souza-Neiras GC Cassiano ACP Joazeiro CJ Fontes CR Bonini-Domingos AAR D'Almeida Couto MM Povoa LC Mattos CE Cavasini ARB Rossit RLD Machado, Trans R Soc Trop Med Hyg 2009 103 672 678 10.1016/j.trstmh.2008.07.018 18804827
18. Susceptibility of Anopheles aquasalis and An.darlingi to Plasmodium vivax VK210 and VK247. ANM Da Silva CCB Santos RN Lacerda RLD Machado MM Póvoa, Mem Inst Oswaldo Cruz 2006 101 547 550 17072460
19. Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in Southern Mexico. L Gonzalez-Ceron MH Rodríguez JC Entel C Villarreal KC Kain JE Hernandez, Infect Immun 1999 67 410 412 9864243
20. Analysis of circumsporozoite protein-specific immune responses following recent infection with Plasmodium vivax. CS Vilai S Looareesuwan MF Good, Am J Trop Med Hyg 2004 71 29 39 15238685
21. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. IS Soares G Levitus JM Souza HA Del Portillo MM Rodrigues, Infect Immun 1997 65 1606 1614 9125537
22. Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax. MB Barbedo R Ricci MCS Jimenez MG Cunha SS Yazdani CE Chitnis MM Rodrigues IS Soares, Mem Inst Oswaldo Cruz 2007 102 335 339 10.1590/S0074- 02762007005000040 17568939
23. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection. BC Mfalo F Gentil DY Bargieri FT Costa MM Rodrigues IS Soares, Microbes Infect 2008 10 1266 1273 10.1016/j.micinf.2008.07.023 18692152
24. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys. M Arevalo-Herrera A Castellanos SS Yazdani AR Shakri CE Chitnis R Dominik S Herrera, Am J Trop Med Hyg 2005 73 25 31 16291763
25. Safety and elicitation of humoral and cellular responses in Colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine. S Herrera A Bonelo BL Perlaza OL Fernandez L Victoria AM Lenis L Soto H Hurtado LM Acuna JD Velez R Palacios M Chen-Mok G Corradin M Arevalo-Herrera, Am J Trop Med Hyg 2005 73 3 9 16291760
26. Plasmodium vivax malaria vaccine development. M Arevalo-Herrera S Herrera, Mol Immunol 2001 38 443 455 10.1016/S0161-5890(01)00080-3 11741694
27. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. MH Rodrigues KM Rodrigues TR Oliveira AN Cômodo MM Rodrigues CH Kocken AW Thomas IS Soares, Int J Parasitol 2005 35 185 192 10.1016/j.ijpara.2004.11.003 15710439
28. An update on the search for a Plasmodium vivax vaccine. S Herrera G Corradin M Arevalo-Herrera, Trends Parasitol 2007 23 122 128 10.1016/j.pt.2007.01.008 17258937
29. Towards a vaccine against Plasmodium vivax malaria. JG Beeson BS Crabb, Plos Med 2007 4 1862 1864 10.1371/journal.pmed.0040350
30. What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines. MA Penny N Maire A Studer A Schapira TA Smith, Plos One 2008 3 3193 10.1371/journal.pone.0003193 18784833
31. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. CL King P Michon AR Shakri A Marcotty D Stanisic PA Zimmerman JL Cole-Tobian I Mueller CE Chitnis, Proc Natl Acad Sci USA 2008 105 8363 8368 10.1073/pnas.0800371105 18523022
32. Infection of Anopheles (Kerteszia) cruzii by Plasmodium vivax and Plasmodium vivax variant VK247 in the municipalities of Sao Vicente and Juquitiba, Sao Paulo. MS Branquinho MT Marrelli I Curado D Natal JM Barata R Tubaki GC Carreri-Bruno RT de Menezes JK Kloetzel, Rev Panam Salud Publica 1997 2 189 193 10.1590/S1020-49891997000900004 9445765
33. Correlation between positive serology for Plasmodium vivax-like/ Plasmodium simiovale malaria parasites in the human and anopheline populations in the state of Acre, Brazil. MT Marrelli MS Branquinho EH Hoffman CB Taipe-Lagos D Natal JK Kloetzel, Trans R Soc Trop Med Hyg 1998 92 149 151 10.1016/S0035-9203(98)90723-4 9764317
34. Correlation between Plasmodium vivax variants in Belém, Par State, Brazil and symptoms and clearence of parasitemia. RLD Machado AF Figueriredo-Filho VSP Calvosa JM Nascimento MM Póvoa, J Infec Dis 2003 7 175 177
35. Evolutionary origin of human and primate malarias: Evidence from the circumsporozoite protein gene. AA Escalante E Barrio FJ Ayala, Mol Biol Evol 1995 12 616 626 7659017
36. Host switch leads to emergence of Plasmodium vivax malaria in humans. J Mu DA Joy J Duan Y Huang J Carlton J Walker J Barnwell P Beerli MA Charleston OG Pybus X-Z Su, Mol Biol Evol 2005 22 1686 1693 10.1093/molbev/msi160 15858201
37. Meager genetic variability of the human malaria agent Plasmodium vivax. MC Leclerc P Durand C Gauthier S Patot N Billotte M Menegon C Severini FJ Ayala F Renaud, Proc Natl Acad Sci USA 2004 101 14455 14460 10.1073/pnas.0405186101 15328406
38. Comparative evolutionary genomics of human malaria parasites. JM Carlton AA Escalante D Neafsey SK Volkman, Trends Parasitol 2008 24 12 545 550 10.1016/j.pt.2008.09.003 18938107
39. Plasmodium vivax: older and wiser? VA Snewin S Longacre PH David, Res Immunol 1991 142 631 636 10.1016/0923-2494(91)90140-E 1817289
40. Phenotype and genotype diversity in the circumsporozoite proteins of Plasmodium vivax in Thailand. P Rongnoparut N Supsamran J Sattabongkot N Suwanabun R Rosenberg, Mol Biochem Parasitol 1995 74 201 210 10.1016/0166-6851(95)02504-9 8719161
41. DNA bioprints: simple non-isotopic DNA fingerprints with biotinnylated probes. SDJ Pena AM Macedo NF Gontijo AM Medeiros JC Ribeiro, Eletrophoresis 1991 12 14 52 10.1002/elps.1150120209
42. Identification of the four species of human malaria parasites by nested PCR that targets variant sequences in the small subunit rRNA gene. M Kimura O Kneko Q Liu M Zhou F Kawamoto Y Wataya S Otani Y Yamaguchi K Tanake, Parasitol Intern 1997 46 91 95 10.1016/S1383-5769(97)00013-5
43. A new polymerase chain reaction/restriction fragment lenght polymorphism protocol for Plasmodium vivax circumsporozoite protein genotype (VK210, VK247, and P. vivax-like) determination. RT Alves MM Póvoa IF Goldman CE Cavasini AR Rossit RLD Machado, Diag Microbiol Infec Dis 2007 59 415 419 10.1016/j.diagmicrobio.2007.06.019 (Pubitemid 350184229)
44. Molecular epidemiology of Plasmodium vivax in the State of Amazonas, Brazil. PD Santos-Ciminera MGC Alecrim DR Roberts GV Quinnan Jr, Acta Trop 2007 102 38 46 10.1016/j.actatropica.2007.02.013 17397788
45. The neighbor-joining method: a new method for reconstructing phylogenetics trees. N Saitou M Nei, Mol Biol Evol 1987 17 1542 1557
46. Molecular evolutionary genetics analysis, version 1.0. S Kumar K Tamura M Nei, Pennsylvania State University, University Park
47. Antigenicity, Immunogenicity and protective efficacy of Plasmodium vivax MSP1 PV200L: a potencial malaria vaccine subunit. A Valderrama-Aguirre G Quintero A Gomez A Castellanos Y Pérez F Méndez M Arévalo-Herrera S Herrera, Am J Trop Med Hyg 2005 73 16 24 16291762
48. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein. S Herrera A Bonelo BL Perlaza AZ Valencia C Cifuentes S Hurtado G Quintero JA López G Corradin M Arevalo-Herrera, Int J Parasitol 2004 34 1535 46 10.1016/j.ijpara.2004.10.009 15582530
49. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. MH Rodrigues KM Rodrigues TR Oliveira AN Comodo MM Rodrigues CH Kocken AW Thomas IS Soares, Int J Parasitol 2005 35 185 192 10.1016/j.ijpara.2004.11.003 15710439
50. Anti-Plasmodium vivax duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon. IP Cerávolo O Bruna-Romero EM Braga CJ Fontes CF Brito JM Souza AU Krettli JH Adams LH Carvalho, Am J Trop Med Hyg 2005 72 75 681
51. The R Foundation for Statistical Computing. http://www.r-project.org